regulation accounts for 7 of the 10 tracked stories, while 3 other categories carry the remainder. Centers for Disease Control and Prevention (CDC) is most often covered alongside Department of Health and Human Services (HHS), which appears in 4 of these 10 stories.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Centers for Disease Control and Prevention (CDC)
regulation accounts for 7 of the 10 tracked stories, while 3 other categories carry the remainder. Centers for Disease Control and Prevention (CDC) is most often covered alongside Department of Health and Human Services (HHS), which appears in 4 of these 10 stories. Across a 146-day span, the pace is roughly 0.5 stories per week. The busiest single day carried 3. The tracked stories average 10 original sources each. We currently track 10 Cross-Sector stories that mention Centers for Disease Control and Prevention (CDC), published between February 20, 2026 and July 15, 2026. 70% of these stories carry negative sentiment.
Stories tracked
10
Per week
0.5
Negative
70%
Sources per story
10
Computed from the 10 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Centers for Disease Control and Prevention (CDC). Shared-story counts are live from our verified record — not editorial picks.
The CDC's health alert on a cyclosporiasis outbreak with 5,100 suspected cases presents urgent needs in the biotech sector for rapid diagnostics, antiparasitic drug development, and food safety technologies. The parasite Cyclospora cayetanensis, with its long incubation period, challenges traditional detection methods, while treatment relies on a decades-old antibiotic. Innovators could capitalize on multiplex PCR panels and next-generation sequencing for outbreak tracking.
A federal judge has issued a temporary injunction against the vaccine policy agenda proposed by Robert F. Kennedy Jr., citing potential risks to public health infrastructure. While the ruling provides a reprieve for existing immunization standards, experts warn that the ongoing legal and political battle could further erode public confidence in scientific institutions.
A comprehensive retrospective analysis has identified over 150,000 COVID-19 deaths that went unrecorded during the early stages of the pandemic. The findings underscore critical failures in the nation's public health data infrastructure and the diagnostic testing limitations of 2020.
Preliminary CDC data indicates that the 2025-2026 influenza vaccine provided lower-than-expected protection, with effectiveness falling to approximately 32%. The findings highlight a significant mismatch between the vaccine's composition and the dominant H3N2 variant, sparking calls for faster manufacturing platforms.
The growing trend of patients requesting to keep biological remains—from placentas for consumption to surgical bone for jewelry—is creating significant clinical and regulatory challenges. Medical experts warn that these practices carry substantial risks of infection and cross-contamination, necessitating clearer institutional policies.
Rising temperatures and extreme weather events are compromising the safety and reliability of drinking water systems across the United States. This infrastructure crisis is forcing a massive regulatory shift and driving demand for advanced health IT solutions to monitor and mitigate waterborne health risks.
California and 14 other states have filed a major lawsuit against the Trump administration, challenging recent modifications to the federally recommended childhood immunization schedule. The legal action alleges that the administration bypassed established scientific protocols and administrative procedures, potentially undermining public health mandates and vaccine confidence nationwide.
California and 14 other states have filed a major lawsuit against the Trump administration, challenging recent federal changes to the national childhood vaccine schedule. The legal action alleges that the administration's revisions bypass scientific consensus and violate established administrative procedures.
A coalition of more than a dozen states, including Arizona, has filed a lawsuit against the Trump administration to block the rollback of CDC-recommended childhood vaccinations. The plaintiffs argue the policy change is illegal and poses an immediate threat to public health by undermining established immunization standards.
The DeSantis administration is facing intense scrutiny for implementing deep cuts to HIV assistance programs despite legislative appropriations intended to bolster public health. Lawmakers are accusing the executive branch of 'kneecapping' the Legislature by bypassing budgetary intent and jeopardizing care in a state with some of the nation's highest infection rates.
